InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the full record of transactions filed by Mayer Howard, Director. Insider active across 1 company, notably Entasis Therapeutics Holdings Inc.. In total, 2 filings have been published. Activity tracked since 18 January 2022. The latest transaction was filed on 7 July 2022 (U). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
Mayer Howard is a Director at Entasis Therapeutics Holdings Inc. In this role, he participates in the governance of the company and strategic decision-making. His experience in the pharmaceutical sector allows him to provide valuable insights on industry issues. He collaborates with other board members to ensure the company's compliance and performance.